Furthermore, sensitization of resistant tumor spheroids to ALK inhibition can be achieved not only through metabolic reprogramming via SREBP-1 inhibition but also by direct pharmacological induction of ferroptosis. The gene discussed is ALK; the disease is neoplasm.